These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20861851)

  • 1. Molecular and functional studies of tyrosinase variants among Indian oculocutaneous albinism type 1 patients.
    Chaki M; Sengupta M; Mondal M; Bhattacharya A; Mallick S; Bhadra R; ; Ray K
    J Invest Dermatol; 2011 Jan; 131(1):260-2. PubMed ID: 20861851
    [No Abstract]   [Full Text] [Related]  

  • 2. Five novel mutations in tyrosinase gene of Japanese and Indian patients with oculocutaneous albinism type I (OCA1).
    Miyamura Y; Verma IC; Saxena R; Hoshi M; Murase A; Nakamura E; Kono M; Suzuki T; Yasue S; Shibata S; Sakakibara A; Tomita Y
    J Invest Dermatol; 2005 Aug; 125(2):397-8. PubMed ID: 16098056
    [No Abstract]   [Full Text] [Related]  

  • 3. The molecular basis of type I (tyrosinase-deficient) human oculocutaneous albinism.
    Giebel LB; Spritz RA
    Pigment Cell Res; 1992; Suppl 2():101-6. PubMed ID: 1409411
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism (OCA1).
    Spritz RA; Oh J; Fukai K; Holmes SA; Ho L; Chitayat D; France TD; Musarella MA; Orlow SJ; Schnur RE; Weleber RG; Levin AV
    Hum Mutat; 1997; 10(2):171-4. PubMed ID: 9259202
    [No Abstract]   [Full Text] [Related]  

  • 5. The R402Q tyrosinase variant does not cause autosomal recessive ocular albinism.
    Oetting WS; Pietsch J; Brott MJ; Savage S; Fryer JP; Summers CG; King RA
    Am J Med Genet A; 2009 Mar; 149A(3):466-9. PubMed ID: 19208379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase gene mutations in type I (tyrosinase-deficient) oculocutaneous albinism define two clusters of missense substitutions.
    Tripathi RK; Strunk KM; Giebel LB; Weleber RG; Spritz RA
    Am J Med Genet; 1992 Jul; 43(5):865-71. PubMed ID: 1642278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OCA1 in different ethnic groups of india is primarily due to founder mutations in the tyrosinase gene.
    Chaki M; Sengupta M; Mukhopadhyay A; Subba Rao I; Majumder PP; Das M; Samanta S; Ray K
    Ann Hum Genet; 2006 Sep; 70(Pt 5):623-30. PubMed ID: 16907708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene symbol: TYR. Disease: Albinism, oculocutaneous 1.
    Patrosso MC; Lando G; Penco S
    Hum Genet; 2008 Oct; 124(3):294. PubMed ID: 18846608
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutations of the tyrosinase gene in Indo-Pakistani patients with type I (tyrosinase-deficient) oculocutaneous albinism (OCA).
    Tripathi RK; Bundey S; Musarella MA; Droetto S; Strunk KM; Holmes SA; Spritz RA
    Am J Hum Genet; 1993 Dec; 53(6):1173-9. PubMed ID: 7902671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).
    Lee ST; Nicholls RD; Schnur RE; Guida LC; Lu-Kuo J; Spinner NB; Zackai EH; Spritz RA
    Hum Mol Genet; 1994 Nov; 3(11):2047-51. PubMed ID: 7874125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New nonsense mutation (p.E250X) in the tyrosinase gene of a patient with oculocutaneous albinism type 1A].
    Aquaron R; Hesse S; Badens C; Bonerandi JJ
    Ann Dermatol Venereol; 2009 Jan; 136(1):57-9. PubMed ID: 19171234
    [No Abstract]   [Full Text] [Related]  

  • 12. A tyrosinase gene missense mutation in temperature-sensitive type I oculocutaneous albinism. A human homologue to the Siamese cat and the Himalayan mouse.
    Giebel LB; Tripathi RK; King RA; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1119-22. PubMed ID: 1900309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene symbol: TYR. Disease: Albinism, oculocutaneous 1.
    Ray K; Chaki M; Mukhopadhyay A
    Hum Genet; 2005 Jul; 117(2-3):299. PubMed ID: 16156027
    [No Abstract]   [Full Text] [Related]  

  • 14. Temperature sensitive oculocutaneous albinism associated with missense changes in the tyrosinase gene.
    Wang T; Waters CT; Jakins T; Yates JR; Trump D; Bradshaw K; Moore AT
    Br J Ophthalmol; 2005 Oct; 89(10):1383-4. PubMed ID: 16170149
    [No Abstract]   [Full Text] [Related]  

  • 15. Single-strand conformation polymorphism analysis of point mutation in a tyrosinase-negative oculocutaneous albinism.
    Park KC; Kim KH; Lee YS; Kwon BS
    J Inherit Metab Dis; 1994; 17(1):123-6. PubMed ID: 8051921
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular basis of type I (tyrosinase-related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene.
    Oetting WS; King RA
    Hum Mutat; 1993; 2(1):1-6. PubMed ID: 8477259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oculocutaneous albinism and analysis of tyrosinase gene in Japanese patients.
    Tomita Y; Miyamura Y
    Nagoya J Med Sci; 1998 Oct; 61(3-4):97-102. PubMed ID: 9879192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I oculocutaneous albinism associated with a full-length deletion of the tyrosinase gene.
    Schnur RE; Sellinger BT; Holmes SA; Wick PA; Tatsumura YO; Spritz RA
    J Invest Dermatol; 1996 May; 106(5):1137-40. PubMed ID: 8618053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonsense mutation in the tyrosinase gene of Afghan patients with tyrosinase negative (type IA) oculocutaneous albinism.
    Giebel LB; Musarella MA; Spritz RA
    J Med Genet; 1991 Jul; 28(7):464-7. PubMed ID: 1832718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous tyrosinase gene mutation in an American black with tyrosinase-negative (type IA) oculocutaneous albinism.
    Spritz RA; Strunk KM; Hsieh CL; Sekhon GS; Francke U
    Am J Hum Genet; 1991 Feb; 48(2):318-24. PubMed ID: 1899321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.